{"id":"W2255223807","doi":"10.1093/eurheartj/ehv643","title":"Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1","year":2016,"lang":"en","type":"review","venue":"European Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Cilag; Janssen Pharmaceuticals; St. Jude Medical; AstraZeneca; Allergan; National Institutes of Health; H. Lundbeck A/S; Servier; Astellas Pharma; Daiichi-Sankyo; Bundesministerium für Bildung und Forschung; Fondation Leducq; British Heart Foundation; European Society of Cardiology; Boston Scientific Corporation; Bayer Vital; Bristol-Myers Squibb; Eli Lilly and Company; CSL Behring; Alere; Bayer HealthCare; European Commission; Sanofi; Deutsche Forschungsgemeinschaft; GlaxoSmithKline; Pfizer","keywords":"Medicine; Atrial fibrillation; Stroke (engine); Warfarin; Internal medicine; Cardiology; Coronary artery disease; Concomitant; Embolism; Cardioversion; Thrombus; Anticoagulant","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001351474,0.000328769,0.001187527,0.0003323821,0.0001679706,0.0001722051,0.00007117315,0.00008861953,0.00005163114],"category_scores_gemma":[0.0001822625,0.0002063611,0.0005934068,0.0001630144,0.00004172741,0.0002256254,0.00007759161,0.0002554411,0.00002998792],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007302999,"about_ca_system_score_gemma":0.0001454229,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":4.67922e-7,"about_ca_topic_score_gemma":5.435849e-7,"domain_scores_codex":[0.9975625,0.0004656064,0.0008424892,0.0003282238,0.000456339,0.0003448187],"domain_scores_gemma":[0.9988551,0.0001429803,0.0005191285,0.0001935421,0.00009549284,0.0001937333],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003910398,0.00001352761,0.1586668,0.001966813,0.000682967,0.0000638268,0.00005988658,0.00001091963,5.896478e-7,0.00001253877,0.001074616,0.8370565],"study_design_scores_gemma":[0.0062948,0.0005987159,0.07033183,0.01160481,0.001495846,0.0001165597,0.000006354079,0.00001245533,2.416532e-7,0.000006684334,0.909278,0.0002536909],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0263963,0.9667193,0.0007891754,0.000395702,0.001058758,0.004354437,0.00006886368,0.00004783276,0.0001696632],"genre_scores_gemma":[0.00246545,0.9842697,0.002737219,0.000046274,0.009135943,0.000002790616,0.0002523292,0.0001541628,0.0009361357],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9082034,"threshold_uncertainty_score":0.8415163,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1625148361972724,"score_gpt":0.3966455082149066,"score_spread":0.2341306720176341,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}